جست‌وجوی استاد و پژوهشگر

Nandika Bandaraمشاهده پروفایل

دانشیار

• Food Science
• Protein Chemistry
• Nanotechnology
• +۴ مورد دیگر

Dr. Nandika Bandara serves as Associate Professor and Tier 2 Canada Research Chair in Food Proteins and Bioproducts at the University of Manitoba's Department of Food and Human Nutritional Sciences within the Faculty of Agricultural and Food Sciences. Her research program focuses on advancing sustainable protein technologies for food, materials, and bioproduct applications through integration of material science and nanotechnology. Education: CFS (Certified Food Scientist), Institute of Food Technologists / International Food Science Certification Council PhD (Food Science & Bioresource Technology), University of Alberta, Canada MSc (Food Science & Technology), University of Alberta, Canada BSc (Agriculture), University of Peradeniya, Sri Lanka Dr. Bandara's research explores protein and biopolymer-based nanostructures for bioactive delivery, sustainable protein extraction from Canadian crops and byproducts, and renewable biopolymers for food packaging and biomedical materials. Her lab investigates novel processing technologies' effects on protein structure-function relationships using advanced characterization techniques. Current projects include protein-lipid conjugation for nanodelivery systems, feather keratin-based wound-healing materials, and deep eutectic solvents for protein extraction. Her publication record demonstrates strong focus on plant protein valorization, nanodelivery systems, and functional materials. Key trends include development of electrospun nanofibers, protein-based packaging films reinforced with nanocellulose, and metabolomics approaches for bioactive compound analysis in Canadian berries. The research bridges fundamental protein chemistry with industrial applications in sustainable food systems. Awards and Honors: Outstanding Volunteer Service Award of the Food Chemistry Division at Institute of Food Technologists (IFT) - 2019/2020 Institute of Food Technologists (IFT) Emerging Leaders Network (ELN) Program finalist - 2019 Natural Science and Engineering Research Council (NSERC) of Canada Postdoctoral Fellowship - 2018 Agricultural Institute of Canada Foundations' (AICF) Karl C Iverson Agricultural Scholarship - 2016 MITACS Accelerate Graduate Scholarship - 2015 Queen Elizabeth II Doctoral Graduate Scholarship - 2015 American Oil Chemist Society Honored Student Award - 2015 Graduate Student Teaching Award of the Faculty of Graduate Studies and Research/ Faculty of Agricultural, Life and Environmental Sciences, University of Alberta - 2015 Alberta Innovates Technology Futures Graduate Student Doctoral Scholarship Dr. Bandara actively supervises graduate students through the University of Manitoba's Food and Human Nutritional Sciences program and holds an adjunct professorship at Dalhousie University. She serves as Associate Editor for Food Chemistry Journal and on the editorial board of Food Research International. Her research is supported by her Canada Research Chair position and industry partnerships focused on Canadian agricultural innovation. She directs the Food Proteins and Bioproducts Lab at the Richardson Centre for Food Technology and Research, which specializes in protein characterization, nanomaterial development, and sustainable extraction technologies. The lab collaborates with researchers across Canada and internationally to translate fundamental discoveries into industrial applications for food, packaging, and biomedical sectors.

Alessandra Luchiniمشاهده پروفایل

استاد

• Nanotechnology
• Proteomics
• Molecular Medicine
• +۳ مورد دیگر

Alessandra Luchini serves as Professor in George Mason University's School of Systems Biology and the Center for Applied Proteomics and Molecular Medicine (CAPMM), where she pioneers nanotechnology solutions for cancer and infectious disease diagnostics. Her work bridges biomolecular interface engineering with clinical translation through advanced proteomic platforms. Education Ph.D. from University of Padova, Italy Research Focus : Dr. Luchini's program centers on nanoproteomics for biomarker discovery, specifically developing hydrogel-based affinity capture systems to detect urinary biomarkers of Lyme disease, Chagas disease, and tuberculosis. Her lab innovates in biomimetic membrane models using neutron reflectometry to study pathogen-host interactions, while translating findings into point-of-care diagnostic devices through CAPMM's clinical partnerships. Publication Trends : Recent work (2024-2025) reveals three converging trajectories: (1) urinary peptide diagnostics for tick-borne illnesses validated against clinical symptom scores, (2) engineered nanoparticle networks for pathogen sequestration in blood/plasma, and (3) membrane biophysics studies enabling targeted drug delivery. This integration of basic membrane science with clinical proteomics defines her translational approach. Awards 2023 SCHEV Outstanding Faculty Award for Virginia higher education Research Leadership : As CAPMM principal investigator, Dr. Luchini directs NIH-funded projects developing FDA-cleared diagnostic platforms. Her team collaborates with CDC on Babesia diagnostics and with oncology centers on field cancerization proteomics, while mentoring postdocs in nanoparticle engineering and mass spectrometry techniques. Infrastructure : The CAPMM core facility houses state-of-the-art mass spectrometers, neutron reflectometers, and GMP-compliant nanoparticle synthesis equipment, supporting her lab's work on urinary biomarker validation and affinity capture technology development.

Sunil V. Pansareمشاهده پروفایل

استاد

• Organic Synthesis
• Enantioselective Catalysis
• Natural Product Synthesis
• +۱ مورد دیگر

Dr. Sunil V. Pansare is a Professor in the Department of Chemistry at Memorial University, Canada. His research focuses on asymmetric organic synthesis using organocatalysis and metal-based catalysis, particularly for natural product synthesis and medicinal chemistry applications. Develops enantioselective synthetic routes for chiral biologically active molecules Specializes in organocatalytic conjugate addition, vinylogous aldol reactions, and C-H bond functionalization Applies methodologies to synthesize alkaloids, marine natural products, and functionalized heterocycles His group's recent work emphasizes organocatalyst design for carbon-carbon bond formation and multicomponent reactions for combinatorial chemistry. Key projects target asymmetric synthesis of pyrrolidines, quinolizidines, and hydroxy amino acid motifs. Scientific distinctions include: JACS Hot Paper (2007) for work on diamine catalysts Top 20 most cited minireview in Chemistry—A European Journal (2011) The Pansare Group has trained numerous researchers including Moorthy N.V.G., Rajender Dyapa, Rakesh Thorat, and Kaivalya Kulkarni. The group actively seeks new PhD candidates interested in organic synthesis and asymmetric catalysis.

Matthias Rareyمشاهده پروفایل

استاد

• Bioinformatics
• Cheminformatics
• Algorithmic Molecular Design
• +۵ مورد دیگر

Prof. Dr. Matthias Rarey is a computer scientist and Professor at the University of Hamburg's Center for Bioinformatics. He holds a Ph.D. in Computer Science from the University of Bonn (1996) and has been leading the Algorithmic Molecular Design working group since 2002. His research focuses on molecular design algorithms, cheminformatics tools, and 3D bioinformatics. Co-founder of BioSolveIT GmbH Former cheminformatics group leader at Fraunhofer SCAI Former researcher at SmithKline Beecham and Roche Bioscience Head of Helmholtz Data Science Graduate School DASHH Director of Center for Data and Computing in Natural Science (CDCS) Research interests span algorithmic molecular design, cheminformatics, structure-based drug discovery, and machine learning applications in bioactivity prediction. His group developed widely used tools like FlexX, PoseView, and SpaceLight for molecular modeling and fragment space analysis. Recent publications focus on geometric pattern matching in protein-ligand interfaces, combinatorial fragment space encoding, adverse drug reaction network analysis, and efficient shape-based virtual screening. The work emphasizes scalable algorithms for billion-sized compound libraries and integration of machine learning with traditional cheminformatics approaches. Scientific awards include: GMD Award 1996 (Best Dissertation) GMD Award 2000 (Best Project) NRW Wissenschaftspreis 2002 Corwin Hansch Award 2005 Emerging Technologies Award 2011 Norddeutscher Wissenschaftspreis 2020 Academic leadership roles: Founding director of Center for Bioinformatics Co-founder of M.Sc. Bioinformatics and B.Sc. Computing in Science programs Chair of doctoral committee at Faculty of Computer Science Member of EMBL-EBI's Molecular and Cellular Structure advisory board Former Associate Editor of Journal of Chemical Information and Modeling

Armando Jorge Domingues Silvestreمشاهده پروفایل

استاد

• Chemistry
• Polymer Science
• Renewable Materials
• +۳ مورد دیگر

Armando J. D. Silvestre is a Full Professor at the Department of Chemistry, University of Aveiro. He holds academic degrees including a Licenciatura in Chemistry (1990), PhD in Chemistry (1994), and Agregação in Chemistry (2008) from the University of Aveiro. His research focuses on renewable materials, circular economy, and functional biomaterials. Research interests include: Development of biopolymer-based functional materials Valorization of biological residues for value-added chemicals Novel polymeric materials from renewable resources Sustainable nanocomposites and coatings Professor Silvestre has supervised 18 MSc and 11 PhD students to completion and currently mentors 3 PhD and 3 MSc candidates. Research projects include EU-funded initiatives like AFORE (Forest Biorefineries) and national projects on membrane technology and biomass valorization. Scientific contributions include over 180 SCI journal publications and patents on extraction methods. He serves on editorial boards for Industrial Crops and Products and actively participates in academic activities including Erasmus coordination and Bologna process implementation.

• Nanotechnology-based bioanalysis
• Mass spectrometry
• Lateral flow immunoassay
• +۵ مورد دیگر

Dr. Chang Lei is an ARC Discovery Early Career Researcher Award (DECRA) Fellow at the Department of Medical Sciences within the Faculty of Medicine and Health at The University of Sydney. She is also a member of The University of Sydney Nano Institute and the Charles Perkins Centre. With expertise in nanotechnology-based bioanalysis, mass spectrometry, lateral flow immunoassay, and tissue regeneration, Dr. Lei leads several innovative research projects focused on advancing healthcare through nanotechnology. Dr. Lei completed her PhD at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland (UQ). Her academic journey includes receiving the Queensland Government Advance Queensland Research Fellowship, the UQ Amplify Fellowship in 2021, and the prestigious ARC DECRA in 2024. Her research interests span across nanotechnology applications in healthcare, with particular focus on: Developing novel nanomaterials for single-cell metabolomics analysis Creating affordable and ultra-sensitive biomarker detection platforms Engineering silica bio-nanomaterials for stem cell differentiation and bone repair Advancing lateral flow immunoassay technologies using nanomaterials Applying nanotechnology to dental and craniofacial regeneration Dr. Lei's publication record demonstrates a strong focus on nanotechnology applications across multiple disciplines. Her recent work shows increasing emphasis on medical applications of nanomaterials, particularly in diagnostics, cancer therapy, and tissue regeneration. She has published in high-impact journals including Nature Science Review, Small, Biosensors and Bioelectronics, Angewandte Chemie, and Advanced Materials. Dr. Lei has received several notable awards and honors: 2024 ARC DECRA Fellow 2021 The University of Queensland Amplify Fellow 2020 GC Minimum Intervention Dentistry Research Award 2017 Advanced Queensland Research Fellow As a reviewer for scientific journals such as Science Advances, Journal of Nanobiotechnology, and Journal of Materials Chemistry B, and for ARC and NHMRC grants, Dr. Lei actively contributes to the scientific community. She also serves as an editor for Frontiers in Bioengineering and Biotechnology and Nano TransMed. Her current research projects are supported by grants including the ARC DECRA and the FMH Start-up Scheme. Dr. Lei is actively involved in several research groups and initiatives: Member of The University of Sydney Nano Institute Member of the Charles Perkins Centre Member of Australian and New Zealand Society for Mass Spectrometry Member of The Australian Materials Research Society Member of the Australian Nanotechnology Network

Vincent Ferrièresمشاهده پروفایل

استاد

• Glycochemistry
• Organic Chemistry
• Bioorganic Chemistry
• +۵ مورد دیگر

Vincent Ferrières is a Full Professor at École Nationale Supérieure de Chimie de Rennes (ENSCR), part of the University of Rennes, where he leads the Organic Chemistry and Interfaces research team within the ISCR (UMR CNRS 6226). He is actively involved in research, teaching, and academic service, including membership and treasurer roles in the French Group of Glycosciences (GFG) and editorial board membership for Molecules . His research focuses on glycochemistry , organic synthesis , and chemical biology , particularly in developing bioactive carbohydrate-based molecules with therapeutic potential. His work spans synthetic methodology, structure-activity studies, and applications in immunology and antimicrobial therapy. Collaborations include institutions in France, the Czech Republic, Morocco, India, and industrial partners. His recent publications reflect a strong trend in medicinal glycochemistry , with emphasis on immunomodulatory glycoconjugates, antifungal agents, and synthetic strategies for complex carbohydrates. These works integrate organic synthesis with biological evaluation, demonstrating interdisciplinary impact. Member and Treasurer, French Group of Glycosciences (GFG) Editorial Board Member, Molecules He has supervised 14 completed PhD theses and 3 ongoing , mentored 3 postdoctoral fellows , and secured 17 research contracts as principal investigator and 3 as partner , reflecting sustained funding and academic leadership. His research team operates within the ISCR-CNRS, a major interdisciplinary chemistry institute. He teaches courses in glycochemistry , organic chemistry , and chromatography , contributing to both undergraduate and graduate education in chemical sciences.

Stefan Franceمشاهده پروفایل

استاد

• Organic Chemistry
• Synthetic Methods Development
• Natural Products Synthesis
• +۳ مورد دیگر

Stefan France serves as Professor and Associate Chair for Graduate Studies in the School of Chemistry and Biochemistry at Georgia Institute of Technology, where he leads an active research program spanning organic synthesis methodology, natural products, and medicinal chemistry. His work develops innovative carbon-carbon and carbon-heteroatom bond formations for therapeutic applications targeting cancer, HIV, diabetes, and neurological disorders. Education: B.S. Chemistry, Duke University, 2000 M.A. Chemistry, Johns Hopkins University, 2003 Ph.D. Chemistry, Johns Hopkins University, 2005 France's research integrates three interconnected pillars: Method Development focuses on efficient catalytic transformations; Natural Product Synthesis targets biologically active complex molecules through modular approaches; Medicinal Chemistry develops drug candidates via interdisciplinary collaborations. Recent trends emphasize green chemistry applications, forensic pharmaceutical analysis, and heterocyclic synthesis methodologies, particularly in dearomatization, cycloadditions, and sustainable catalysis. His publications reveal growing emphasis on environmentally conscious synthesis, forensic standards development for controlled substances, and atmospheric chemistry of organic nitrates, reflecting interdisciplinary impact across pharmaceutical, environmental, and analytical domains. Scientific Awards: NSF CAREER Award (2011) and multiple Georgia Tech teaching honors including Senior Faculty Outstanding Undergraduate Mentor (2015) NOBCChE Lloyd N. Ferguson Young Scientist Award (2012) and NIH diversity grants ORAU Powe Fellowship (2009) and Ford Foundation Dissertation Fellowship (2004) As Associate Chair for Graduate Studies, France mentors numerous students and directs curriculum development. His research has secured significant funding from NSF, NIH, and industry partners, supporting collaborative projects with biologists and computational chemists for therapeutic development. The France Lab maintains strong industry partnerships for translational research. The France Lab operates under four foundational pillars: Creating Impact through Research and Teaching, Building Platforms for Future Chemists, Collaborative Decision Making, and Inclusive Community Leadership. Active as of Spring 2025, the lab maintains a public Instagram presence showcasing its supportive, diverse research environment focused on advancing chemical synthesis while training next-generation scientists.

Michael Willisمشاهده پروفایل

استاد

• Organic Synthesis
• Catalysis
• Sulfur Functional Groups
• +۴ مورد دیگر

Michael Willis is Professor of Chemistry at the University of Oxford and Fellow of Lincoln College, leading the Willis Research Group with expertise in catalytic organic synthesis. His work bridges academic innovation and industrial pharmaceutical applications through novel sulfur chemistry methodologies. His educational trajectory includes: Undergraduate studies at Imperial College London PhD at University of Cambridge under Professor Steve Ley Postdoctoral research at Harvard University with Professor David Evans Research centers on catalytic sulfur functionalization, particularly using DABSO as a sulfur dioxide surrogate to develop sulfonamide/sulfonimidamide synthesis routes. His group pioneers enantioselective desymmetrization methods and heterocyclic cross-coupling techniques, emphasizing industrial applicability in drug discovery. Key themes include energy-efficient catalysis and sustainable chemistry approaches to complex molecule synthesis. Analysis of recent publications (2021-2023) reveals sustained innovation in sulfur reagent development, with increasing focus on photocatalysis and radical-based transformations for sulfonamide diversification. The work demonstrates strategic progression from fundamental reagent discovery (DABSO) to complex target synthesis with pharmaceutical relevance. Award recognition includes: 2015 Pfizer, AstraZeneca, Syngenta Process Chemistry Research Award 2014 Royal Society of Chemistry Catalysis in Organic Chemistry Award 2008 AstraZeneca Award in Synthetic Organic Chemistry The Willis Group maintains active pharmaceutical industry collaborations while developing next-generation catalytic methods. Current projects focus on expanding sulfur pharmacophore applications and improving synthetic efficiency for agrochemical targets through novel catalytic manifolds.

Maobing Tuمشاهده پروفایل

استاد

• Biomass Processing Chemistry
• Biofuels and Bioenergy
• Bioprocess Engineering
• +۳ مورد دیگر

Maobing Tu is a Professor at the University of Cincinnati, specializing in biomass processing chemistry and biofuel production. His research focuses on biochemical engineering, lignocellulosic biomass conversion, and environmental biotechnology. He holds a PhD from the University of British Columbia (2007) and East China University of Science and Technology (2001). Key research areas include developing sustainable biorefinery processes, mitigating biomass recalcitrance, and enhancing microbial fermentation efficiency. He has secured multiple grants, including an NSF CAREER Award and NSERC Fellowships, supporting projects on lignin valorization, PFAS treatment, and bioprocess engineering. Education: PhD, University of British Columbia, Vancouver, 2007 PhD, East China University of Science and Technology, Shanghai, 2001 Awards: NSF Career Award (2013–2018) NSERC Industry R&D Fellowship (2007–2008) His work spans collaborations on nanocellulose-based materials, microbial fuel cells, and lignin-based piezoelectric materials. Recent grants include federal funding for decarbonizing chemical recovery processes and novel membrane electrolysis systems. Publications highlight advancements in biomass pretreatment, enzyme recycling, and detoxification strategies for biofuel production. Current projects address environmental challenges like PFAS remediation and microbial community dynamics in water systems.

Qiu Wangمشاهده پروفایل

استاد

• Chemical Biology
• Medicinal Chemistry
• Synthetic Organic Chemistry
• +۵ مورد دیگر

Qiu Wang is a Professor of Chemistry at Duke University, where he leads an active research program at the chemistry-biology interface. He holds dual appointments as a Member of the Duke Cancer Institute and Faculty Network Member of the Duke Institute for Brain Sciences, reflecting his interdisciplinary work targeting cancer and neurodegenerative disorders through chemical approaches. His educational foundation includes a B.S. from Wuhan University (China, 1999), Ph.D. from Emory University (2005), and dual postdoctoral fellowships at Harvard University (2005-2007 and 2007-2011) in Chemistry. This rigorous training established his expertise in synthetic methodology and biological applications. Wang's research program focuses on three synergistic pillars: developing bioactive small-molecule probes for disease mechanisms, targeting epigenetic enzymes for novel therapeutics, and creating chemical tools for biomolecule labeling. His group integrates synthetic organic chemistry with molecular/cell biology, genetics, and proteomics to address challenges in cancer and neurodegeneration, emphasizing copper-catalyzed reactions and hyperpolarized imaging technologies. Analysis of his recent publications reveals dominant themes in copper-catalyzed alkene/diene difunctionalization for complex molecule synthesis and the development of $^{15}$N-hyperpolarized MRI probes for metabolic imaging. These works bridge fundamental methodology with biological applications, particularly in cancer metabolism and neurological disorders. His scientific recognition includes: Sloan Research Fellowship (2016) NSF CAREER Award (2015) Wang directs multiple major grants including the Pharmacological Sciences Training Program (2025-2030), New Amination Methods (2025-2030), and hyperpolarized MRI agent development (2025-2027). His Wang Group collaborates extensively across Duke's institutes, developing chemical probes that enable new biological insights and therapeutic strategies for challenging diseases.

Derek S Tanمشاهده پروفایل

استاد

• Chemical Biology
• Medicinal Chemistry
• Biochemistry
• +۳ مورد دیگر

Derek S. Tan is a Professor in the Department of Biochemistry and Biophysics at Weill Cornell Medical College, holding a Tri-Institutional Professor position effective from 2025. His research integrates chemical synthesis with biological applications, focusing on drug discovery, enzyme mechanisms, and therapeutic engineering. He maintains an active research program with continuous NIH funding. Education: Ph.D., Harvard University (2000) B.S., Stanford University (1995) Research Focus: Professor Tan's work spans chemical biology, medicinal chemistry, and microbiology. He designs bioactive molecules targeting bacterial permeability, enzyme inhibition, and cellular therapeutics. Key areas include ubiquitin pathway biochemistry, antibiotic development against Mycobacterium tuberculosis and Plasmodium falciparum , and engineered T-cell therapies for cancer. His interdisciplinary approach bridges synthetic chemistry with translational applications. Publication Trends: Recent articles (2021-2024) demonstrate three primary themes: 1) Development of mechanistic probes for enzyme systems (ubiquitin pathway, aminoacyl-tRNA synthetases), 2) Antibacterial/antiparasitic agent design leveraging bacterial permeability studies, and 3) Cellular engineering strategies including CAR-T micropharmacies for targeted drug activation. The work consistently combines synthetic chemistry innovation with biological validation. Grants: As Principal Investigator of the Tri-institutional PhD Program in Chemical Biology (NIH/NIGMS funded), he leads initiatives spanning 2020-2025 and 2025-2030. This underscores sustained commitment to interdisciplinary training at the chemistry-biology interface.

Albert Gibert Boschمشاهده پروفایل

استادیار

• Bioactivity
• Mesoporous Silica
• Tyrosine Kinase Inhibitor
• +۶ مورد دیگر

Albert Gibert Bosch serves as an Assistant Professor in the Department of Organic and Pharmaceutical Chemistry at IQS School of Engineering, Universitat Ramon Llull. He is an active member of the Pharmaceutical Chemistry Group (GQF) and has been involved in significant research projects spanning from 2014 to 2025. His research spans multiple areas of pharmaceutical chemistry with a focus on drug discovery and development. Key research interests include molecular modeling for drug design, CXCR4 inhibitors for cancer treatment, HIV therapeutics, nanoparticle drug delivery systems, and tyrosine kinase inhibitors. His work demonstrates strong interdisciplinary connections between computational chemistry, medicinal chemistry, and cancer biology. Recent publication trends show a consistent focus on CXCR4 targeting compounds with applications in both oncology (particularly B-cell lymphoma) and HIV treatment. His research utilizes advanced molecular modeling techniques to design novel compounds with therapeutic potential. Dr. Bosch has participated in multiple research projects including DisX4lymph: Design and synthesis of CXCR4 allosteric inhibitors and IRAK4 degraders as potential treatments of B-cell lymphoma (2022-2025), and has been part of the Pharmaceutical Chemistry Group funded by Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) from 2022-2025.

Nicholas H. Oberliesمشاهده پروفایل

استاد

• Natural Products Chemistry
• Drug Discovery
• Herbal Drug Analysis
• +۳ مورد دیگر

Nicholas H. Oberlies is the Patricia A. Sullivan Distinguished Professor of Chemistry and Graduate Director (MS and PhD) in the Department of Chemistry and Biochemistry at the University of North Carolina at Greensboro (UNC-Greensboro). He holds a B.S. in Chemistry from Miami University (1992) and a Ph.D. in Medicinal Chemistry and Pharmacognosy from Purdue University (1997). Before joining UNC-Greensboro in 2009, he conducted research at the Research Triangle Institute (RTI) under Drs. Mansukh Wani and Monroe Wall, renowned for discovering Taxol and Camptothecin. Serves as Principal Investigator for projects funded by the National Cancer Institute (NCI), National Institute of General Medical Sciences (NIGMS), and National Center for Complementary and Alternative Medicine (NCCAM). Research focuses on isolating bioactive compounds from fungi, plants, and bacteria for drug discovery and herbal drug standardization. Key projects include anticancer drug leads from filamentous fungi, milk thistle's hepatoprotective mechanisms, and drug-herb interaction studies. His lab collaborates across disciplines, including pharmacology, virology, and metabolism. Notable awards include the Matt Suffness Young Investigator Award and recognition as a Fellow and Past President of the American Society of Pharmacognosy. Current research teams include postdoctoral scientists, graduate (Ph.D.) students, and undergraduates. His group emphasizes team-based approaches, with projects published in journals like Proceedings of the National Academy of Sciences and Nature Chemical Biology . Labs and facilities include advanced NMR, mass spectrometry, and cell culture setups. Ongoing work explores natural product synthesis, drug delivery systems (e.g., lipid nanoparticles), and metabolomics-guided studies on honeybee diets.

• Metabolomics
• Analytical Chemistry
• Plant-Microbe Interaction
• +۲ مورد دیگر

Rainer Schuhmacher is a Full Professor for Plant and Microbe Metabolomics at the University of Natural Resources and Life Sciences, Vienna (BOKU), affiliated with the Department of Agricultural Sciences and the Institute of Bioanalytics and Agro-Metabolomics in Tulln an der Donau. His research focuses on metabolomics, analytical chemistry, and plant-microbe interactions, with emphasis on fungal secondary metabolites, mycotoxin resistance, and environmental stress responses in crops. He leads projects funded by the Austrian Science Fund (FWF), European Commission, and national agencies. Research interests span: Metabolomic profiling of plant-pathogen interactions (e.g., Fusarium -wheat systems) Stable isotope-assisted techniques for metabolic pathway analysis Cold stress mitigation in plants using Antarctic bacteria Development of computational tools for untargeted metabolomics data processing His work integrates analytical chemistry, bioinformatics, and molecular biology to study metabolic crosstalk in agricultural systems. Awards include the Fritz-Feigl-Preis (2012) and Dr.-Wolfgang-Houska-Preis (2005). He has supervised multiple PhD projects and leads the Plant-Microbe Metabolomics group, managing core metabolomics platforms and international collaborations. Key projects: Chemical crosstalk in mycoparasitic interactions (FWF) Metabolomics of cold stress tolerance mediated by psychrotolerant bacteria Extension of metabolomics platforms for plant-pathogen studies